1282416-50-5Relevant academic research and scientific papers
Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated muc1 glycopeptides and the toll-like receptor 2 agonist pam3CysSer
Wilkinson, Brendan L.,Day, Stephanie,Malins, Lara R.,Apostolopoulos, Vasso,Payne, Richard J.
, p. 1635 - 1639 (2011)
More sugar with your "T": The title candidates comprising per-glycosylated MUC1 peptides, a T-cell helper peptide, and an immunoadjuvant were assembled in high yields using iterative pentafluorophenyl ester-mediated fragment condensations. Following immun
